On the move: 4 rare disease companies hiring now - BioSpace
The company counts among its areas of innovation a proprietary deimmunization platform that uses AI to reengineer proteins with the goal of ...
biospace.com 15
Covers: HealthcareRegulation & PolicyChatbots & LLMsMarkets & InvestmentGovernance & Risk ManagementRetail & E-commerceLegal & CourtsAI Safety & Existential Risk
SpectralAICompletes Data Analysis for U.S. Burn Pivotal Study - Bio Space
Investors should carefully consider the foregoing factors and the otherrisksand uncertainties described in the “Risk Factors” sections of the …
C the Signs Announces Investment From Khosla Ventures to AdvanceAI-Powered Early ...
Following success across the UK's National Health Service identifying breast, ovarian, and colorectal cancers years earlier than traditional …
Noble AI Launches RAIR: An All-in-One, Integrated Risk Assessment & Ingredient ...
Industry-first offering helps companies proactively identifyrisks, quickly replace hazardous ingredients for safer, more sustainable products …
FDA's NewAIGuidance Highlights Risksof Technology, Urges Early Sponsor Engagement
In its 23-page document, the regulator proposes a “risk-based credibility assessment framework” for using AI in the drug product life cycle. Among the …
Cyrus Biotechnology to Present its Protein Engineering Capability, Immunogenicity Risk...
Yifan Song to include data demonstrating Cyrus's hybridAI/screening platform inriskmitigation of protein therapeutics. Cyrus IgG protease …
HowAICould Ease Tension in Clinical Trials - Bio Space
Designating something “safe” in this industry means acceptablerisk.AI can help us improve acceptablerisksif it is used appropriately. However …
The White House, Microsoft, SaS, Foley Hoag & Astellas OfferAIGuidance to Investors. Part One
However, there is a significant amount ofriskin misunderstanding what this technology can and cannot do, which is compounded by the legal landscape …
Neuro Snap's 'Neuro Fold' Is Revolutionizing Enzyme R&D - Bio Space
Enter Neuro Fold, Neuro Snap's proprietary software tool that uses AI to rapidly and accurately create enzyme variants with optimized and desired …
Opinion: Gen AI Is Not a One-Size-Fits-All Solution for Regulatory Operations | Bio Space
Risksof Using Gen AI for Regulatory Compliance ...risksto patient safety. Theriskof data leakage ... TheAI-augmented user can take the best of AI …
Regulation & PolicyChatbots & LLMsAI Safety & Existential RiskHealthcare
Scryb Applauds New Bipartisan $32B Roadmap forAIPolicy from U.S. Senate - Bio Space
...AI systems.[2]. "Scryb is committed to harnessing AI'sfull potential while minimizingrisks. As AI adoption accelerates, the world needs robust …
Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry ...
Bio Space Model Medicines is a generative AI-driven human health company that uses AI to model all of chemistry and human biology to accelerate the creation of …
Cautiously Stepping Into the Future of AI by Stepping Back Into the Past at DIA's MASC
Bio Space... to understand AI risksand to prepare to comply with the EU AI Act is what is needed …
Volpara to Showcase AI Software for Breast Centers at NCBC 2024, Including Lunit ...
Bio Space ... that uses AI to enhance the mammography journey from screening to diagnosis. Thriving Volpara customer community. Members of Volpara's Hive, the …
Scryb Announces Development of New EnterpriseAIVenture | Bio Space
AI riskscan emerge from how a system is used, its interactions with ... Develop further the AI Risk Management Framework focused to introduce …